University of Waterloo to use Cloud DX Tech to Improve Treatment for Neurological Disorders Affecting 1 in 6 People

• Contract with UWaterloo to span years and impact hundreds of patients
• 1 in 6 people are impacted by neurological disorders
• New Connected Health ^TM use case will support patients with neurodegenerative diseases and/or neurological injuries

WATERLOO, ON / ACCESSWIRE / November 10, 2021 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF) , Researchers from the University of Waterloo's Faculty of Health have partnered with Cloud DX, whose Connected Health ^TM Virtual Care Platform will augment care of those suffering with neurological disorders such as Parkinson's disease, stroke, dementia, and more. The team at University of Waterloo will integrate Connected Health ^TM into their research program to collect vital health data insights supplementary to clinic visits. Connected Health ^TM enables care teams to access data gathered from home and create personalized treatments tailored specifically around each patient's needs. The research will start in early 2022. Similar contracts involving the Connected Health ^TM Virtual Care Platform announced so far in 2021 include:

• reimbursed RPM contract with Maxwell Telecare;
• direct to patient e-commerce agreement with Dagamma;
• partnership with Prizm Media; bringing Cloud DX access to more than 1 million patients in North America. ¹

Dr. Bill McIlroy of University of Waterloo said, "With the help of Cloud DX's Connected Health ^TM platform, we'll be able to deliver unprecedented personalized care for each neurological patient. That means the potential for better care that can lead to superior health outcomes and improved quality of life. Having access to this data collected at home provides unique opportunities to transform health monitoring and care. The Cloud DX platform's advancements, along with advances in wearable technologies, will afford our clinicians the opportunity to better adjust and personalize their treatment approach based on individual patients' experiences and measurable numbers acquired at home. It's like the difference between a one-size-fits-all approach versus a custom-tailored wardrobe. Since each patient is unique, the custom-tailored approach creates a better fit and the potential for a vastly superior deliverable."

"While personalized care isn't new, helping neurological patients through the integration of at-home and in-clinic data collection is a new path forward for Virtual Care as a Platform," says Robert Kaul, Founder and CEO of Cloud DX. "Our Connected Health ^TM Virtual Care platform and extensive expertise with chronic illnesses like these help our partners and clients give patients the personalized care they need. We also put people in control of their health journey and bring them closer to their care team. Think about a dementia patient who is prescribed a new medication and develops irregular blood pressure. If they have Connected Health ^TM , their care team is notified of the changed vital sign and can quickly take action; a quick video chat and a fax to the pharmacy and the patient has a new prescription to be monitored on. Our Connected Health ^TM Virtual Care Platform makes it that simple for patients to get improved care and better health outcomes."